Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Checkmate Pharmaceuticals, Inc.Listing unverified | Sell | $671.4K | Unusual size | SEC | |
Checkmate Pharmaceuticals, Inc.Listing unverified | Sell | $287.5K | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | Sell | $388.9K | Unusual size | SEC | |
Akero Therapeutics, Inc.Listing unverified | Sell | $37.9K | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Sell | $56.6K | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Sell | $40.1K | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Sell | $212.2K | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Sell | $59.1K | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Sell | $162.8 | SEC |